The assessment of replication success based on relative effect size (Q65581): Difference between revisions
From MaRDI portal
Changed an Item |
ReferenceBot (talk | contribs) Changed an Item |
||
| Property / cites work | |||
| Property / cites work: Sampling and Bayes' Inference in Scientific Modelling and Robustness / rank | |||
Normal rank | |||
| Property / cites work | |||
| Property / cites work: The Well-Calibrated Bayesian / rank | |||
Normal rank | |||
| Property / cites work | |||
| Property / cites work: Why should clinicians care about Bayesian methods? (With discussions and response) / rank | |||
Normal rank | |||
| Property / cites work | |||
| Property / cites work: Introduction to Randomized Controlled Clinical Trials / rank | |||
Normal rank | |||
| Property / cites work | |||
| Property / cites work: Bayesianly justifiable and relevant frequency calculations for the applied statistician / rank | |||
Normal rank | |||
| Property / cites work | |||
| Property / cites work: Statistical Issues in Drug Development / rank | |||
Normal rank | |||
Revision as of 14:19, 29 July 2024
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The assessment of replication success based on relative effect size |
scientific article |
Statements
16
0 references
2
0 references
1 June 2022
0 references
14 July 2022
0 references
The assessment of replication success based on relative effect size (English)
0 references
power
0 references
replication studies
0 references
sceptical \(p\)-value
0 references
shrinkage
0 references
two-trials rule
0 references
type-I error rate
0 references
0 references
